Harm reduction and hepatitis C: On the ethics and politics of prevention and treatment

References

• Australian Government Department of Health and Ageing (2005). National hepatitis C strategy 2005-2008. Canberra, Australia: Commonwealth of Australia. Retrieved from http://www.health.gov.au/internet/main/publishing.nsf/Content/phd-hepc-strategy-0508-cnt.htm
   Google Scholar
• Ballard K, Elston MA. Medicalisation: A multidimensional concept. Social Theory and Health 2005; 3: 228–241
   Google Scholar
• Barad K. Meeting the universe halfway: Quantum physics and the entanglement of matter and meaning. Duke University Press, Durham and London 2007
   Google Scholar
• Bourgois P, Prince B, Moss A. The everyday violence of hepatitis C among young women in who inject drugs in San Francisco. Human Organization 2004; 63: 253–264
   PubMed Web of Science ®Google Scholar
• Bourgois P, Schonberg J. Righteous dopefiend. University of California Press, Berkeley, CA 2009
   Google Scholar
• Conrad P, Schneider AW. Deviance and medicalisation: From badness to sickness. Mosby, St Louis 1980
   Google Scholar
• Cook C, Kanaef N. The global state of harm reduction 2008: Mapping the response to drug-related HIV and hepatitis C epidemics. International Harm Reduction Association, London 2008
   Google Scholar
• Davis M, Rhodes T. Managing seen and unseen blood associated with drug injcting: Implications for theorising harm reduction for viral risk. International Journal of Drug Policy 2004; 15: 377–384
   Google Scholar
• Family Drug Support (2002). Infectious disease prevention – safe injecting and safe sex practices. Retrieved from http://www.fds.org.au/pdf/FactSheet9_ID&IP.pdf
   Google Scholar
• Fraser S. ‘It's your life!’: Injecting drug users, individual responsibility and hepatitis C prevention. Health 2004; 8: 199–221
   PubMed Web of Science ®Google Scholar
• Fraser S. Hepatitis C and the limits of medicalisation and biological citizenship for people who inject drugs. Addiction Research and Theory 2010; 18: 544–556
   Web of Science ®Google Scholar
• Hathaway AD. From harm reduction to human rights: Bringing liberalism back into drug reform debates. Drug and Alcohol Review 2002; 21: 397–404
   PubMed Web of Science ®Google Scholar
• Hathaway AD. Ushering in another harm reduction era? Discursive authenticity, drug policy and research. Drug and Alcohol Review 2005; 24: 549–550
   PubMed Web of Science ®Google Scholar
• Hopwood M, Treloar C. The experience of interferon-based treatments for hepatitis C infection. Qualitative Health Research 2005; 15: 635–646
   PubMed Web of Science ®Google Scholar
• Hopwood M, Treloar C, Redsull L. Experiences of hepatitis C treatment and its management: What some patients and health professionals say. National Centre in HIV Social Research, University of New South Wales, Sydney 2006
   Google Scholar
• Koester SK. Copping, running, and paraphernalia laws: Contextual variables and needle risk behavior among injection drug users in Denver. Human Organization 1994; 53: 287–295
   Web of Science ®Google Scholar
• Latour B. Reassembling the social: An introduction to actor-network-theory. Oxford University Press, Oxford 2005
   Google Scholar
• Law J. After method: Mess in social science research. Routledge, London and New York, NY 2004
   Google Scholar
• Lupton D. Foucault and the medicalisation critique. Foucault, health and medicine, A Petersen, R Bunton. Routledge, London and New York, NY 1997; 94–110
   Google Scholar
• Maher L, Dixon D. Policing and public health: Law enforcement and harm minimization in a street-level drug market. British Journal of Criminology 1999; 39: 488–512
   Web of Science ®Google Scholar
• Martin, A., Vickerman, P., & Hickman, M. (2010, May 20). Can HCV treatment of active injecting drug users (IDUs) lead to a reduction in HCV transmission? A modelling analysis. Paper presented at the Burnet Institute, Melbourne, Australia.
   Google Scholar
• Miller PG. A critical review of the harm minimization ideology in Australia. Critical Public Health 2001; 11: 167–178
   Google Scholar
• Mol A. Ontological politics: A word and some questions. Actor network theory and after, J Law, J Hassard. Blackwell, Oxford 1999; 74–89
   Google Scholar
• Mol A. The body multiple: Ontology in medical practice. Duke, Durham and London 2002
   Google Scholar
• Mol A, Law J. Complexities: An introduction. Complexities: Social studies of knowledge practices, J Law, A Mol. Duke, Durham and London 2002; 1–22
   Google Scholar
• Moore D. Governing street-based injecting drug users: A critique of heroin overdose prevention in Australia. Social Science and Medicine 2004; 59: 1547–1557
   PubMed Web of Science ®Google Scholar
• Moore D, Fraser S. Putting at risk what we know: Reflecting on the drug-using subject in harm reduction and its political implications. Social Science and Medicine 2006; 62: 3035–3047
   PubMed Web of Science ®Google Scholar
• Porter R. The greatest benefit to mankind: A medical history of humanity. HarperCollins, London 1997
   Google Scholar
• Tomes N. Patient empowerment and the dilemmas of late-modern medicalisation. Lancet 2007; 369: 698–700
   PubMed Web of Science ®Google Scholar
• Turner BS. Medical power and social knowledge, 2nd. Sage, London 1995
   Google Scholar